Investment
Features
FeesSafety
Academy
More
Pluang+

Compare ARK Next Generation Internet ETF (ARKW) vs Novavax Inc (NVAX) Price & Performance

ARK Next Generation Internet ETFTrade
Novavax IncTrade

Price performance (Past 24H)

Key statistics

ARK Next Generation Internet ETF vs Novavax Inc — how do they compare? ARK Next Generation Internet ETF trades at $150.3, while Novavax Inc trades at $7.96 (market cap $1.31B). The key difference: ARK Next Generation Internet ETF is trading nearer its 52-week high, Novavax Inc nearer its low. Which is the better fit depends on your goals.

ARKWNVAX
Sector
Sector/ThematicHealth
52-Week High
$182.20$11.19
52-Week Low
$114.45$6.22
Market Cap
$1.31B
Enterprise Value
$889.30M

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

ARK Next Generation Internet ETF

ARKW trades at $150.88, up 0.87% today, with a bullish technical signal from moving averages but a neutral oscillator stance. The ETF focuses on next-generation internet companies, though key financial ratios are not disclosed in the provided data. Recent news highlights long-term growth potential in AI and cloud infrastructure, balanced by near-term capital spending headwinds.

The outlook is mixed, with strong technical momentum but fundamental metrics unavailable for valuation. Risks include market skepticism on AI investments and sector volatility. Analyst sentiment is cautious, citing near-term challenges despite long-term positioning in transformative technologies.

Novavax Inc

Novavax (NVAX) trades at $7.97, up 1.01% with a mixed technical picture showing bullish overall signals but bearish moving averages. The company reported strong Q2 2026 results, beating revenue and earnings estimates while raising full-year guidance. Despite negative profitability metrics, valuation ratios appear attractive with P/E of 3.14 and EV/EBITDA of 1.72. Recent news highlights progress with Sanofi partnership and cost reduction initiatives.

The outlook remains challenged by negative cash flows and accumulated deficits, but analyst sentiment is positive with 74% buy ratings. Key risks include ongoing operational losses and vaccine demand volatility, while potential upside exists from partnership milestones and adjuvant platform expansion. The stock presents a high-risk opportunity with significant analyst support despite fundamental weaknesses.

Returns comparison

Trailing returns across standard periods

About ARK Next Generation Internet ETF

ARKW is an actively managed ETF that invests in next-generation internet technologies. It focuses on cloud computing, AI, e-commerce, and blockchain innovation, with key holdings like Tesla, Advanced Micro Devices, and Roku.

Read more on ARKW

About Novavax Inc

Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.

Read more on NVAX